Daphne Williams
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Pharmacogenetics and Drug Metabolism, Pancreatic and Hepatic Oncology Research, Complement system in diseases, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Population Pharmacokinetics of Eltrombopag in Healthy Subjects and Patients With Chronic Idiopathic Thrombocytopenic Purpura(2010)83 cited
- Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanoma.(2013)
- → A Phase I Study of Cantuzumab Mertansine Administered as a Single Intravenous Infusion Once Weekly in Patients with Advanced Solid Tumors(2004)51 cited
- → Metabolism, Excretion, and Pharmacokinetics of Oral Brivanib in Patients with Advanced or Metastatic Solid Tumors(2010)25 cited
- → An Oral, Non-Petide, Small Molecule Thrombopoietin Receptor Agonist Increases Platelet Counts in Healthy Subjects.(2004)23 cited
- → A Bayesian Population PK–PD Model of Ispinesib-induced Myelosuppression(2006)20 cited
- → Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans(2011)18 cited
- → Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator(2016)16 cited
- → Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis(2009)15 cited
- → A Bayesian population PK–PD model for ispinesib/docetaxel combination-induced myelosuppression(2008)14 cited